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Abstract
Introduction
Rates of obesity are higher among Canada’s Aboriginal 
First Nation populations than among non-First Nation 
populations. We studied obesity and obesity-related illness 
in a Manitoba First Nation community.
Methods
We conducted a screening study of diabetes and diabetes 
complications in 2003, from which we drew a representa-
tive sample of Manitoba First Nation adults (N = 483). We 
assessed chronic disease and chronic disease risk factors.
Results
Prevalence of obesity and associated comorbidities was 
higher among women than men. By using multivariate 
analysis, we found that factors significantly associated 
with obesity among women were diastolic blood pressure, 
insulin resistance, and employment status. Among men, 
factors were age, apolipoprotein A1 level, apolipoprotein B 
level, and insulin resistance. Seventy-five percent of study 
participants had at least 1 of the following conditions: obe-
sity, dyslipidemia, hypertension, or diabetes. Comorbidity 
was high even among the youngest age groups; 22% of 
men and 43% of women aged 18 to 29 had 2 or more 
chronic conditions. Twenty-two percent of participants had 
undiagnosed hypertension. Participants with undiagnosed 
hypertension had significantly more chronic conditions 
and were more likely to have microalbuminuria than were 
those without hypertension. The number of chronic condi-
tions was not significantly different for participants with 
newly diagnosed hypertension than for those with previ-
ously diagnosed hypertension.
Conclusions
The prevalence of obesity and other chronic conditions 
in the study community is high, especially considering 
the number of young people. Community-based interven-
tions are being undertaken to reduce the excessive rate 
of illness.
Introduction
The Canadian First Nation population has poorer over-
all health than does the general Canadian population (1), 
specifically in terms of chronic diseases, chronic disease 
risk factors (2), and injuries and accidents (3). In Canada, 
First Nation people are 1 of 3 constitutionally recognized 
Aboriginal groups; the other 2 are the Métis and the Inuit. 
In this article, we use the term Aboriginal to report on 
research that included 2 or more of these distinct groups 
if no distinction was made between the groups in the 
analysis. However, if the research included only 1 group, 
we have identified that group. According to the 2005-2006 
Canadian Community Health Survey, the prevalence of 
obesity among people who self-identified as Aboriginal 
and who did not live on reserve land was 20% in Canada’s 
north (Yukon, Northwest Territories, and Nunavut) and 
23% in the rest of Canada (4).
Obesity prevalence appears to be higher among 
First Nation people living on reserves. In Sandy Lake, 
Ontario, the prevalence of obesity (body mass index [BMI] 
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≥30 kg/m2) was 50% for men and 65% for women (5). 
Furthermore, in a First Nation community in Quebec, 91% 
of study participants from a sample of 172 were abdomi-
nally obese (6). The prevalence of obesity was 55% among 
a sample of Alberta First Nation people and 49% among a 
sample of Métis people (7).
Prevalence of obesity-related comorbidities is also high 
among Canadian First Nation people. The prevalence of 
diabetes among Canadian First Nation populations is 
3 to 5 times higher than among the general Canadian 
population (5-8). Hypertension, dyslipidemia, metabolic 
syndrome, and diabetes complications such as cardiovas-
cular disease (CVD), stroke, retinopathy, neuropathy, and 
nephropathy are also major contributors to poor health 
(2,5-10). CVD is one of the leading causes of death in 
Canada, and Aboriginal populations have twice the CVD 
death rate of non-Aboriginal populations (2). In a ran-
dom sample, the rate of CVD was 18% among Canadian 
Aboriginal people and 8% among people of European 
ancestry (2).
Despite the evidence of excess obesity, diabetes, and 
related metabolic conditions among Canada’s First Nation 
populations, few researchers have investigated their coex-
istence in this population. Our purpose was to explore the 
magnitude and effect of obesity and obesity-related comor-
bidities in a Manitoba First Nation.
Methods
Our methods have been previously described (10). 
Briefly, 483 eligible residents of a Manitoba First Nation 
community volunteered in 2003 to participate in a 
screening study for diabetes and diabetes complications. 
A total of 1,356 eligible participants included nonpreg-
nant adults aged 18 years or older who were registered 
Indians and who were residents of the community. Our 
sample (36%, 483 of 1,356) is representative of eligible 
participants by age and sex (10). A registered nurse drew 
venous samples to measure glucose, hemoglobin A1c, 
insulin, total cholesterol, high-density lipoprotein (HDL) 
cholesterol, triglycerides, apolipoprotein A1 (apoA1), 
total apolipoprotein B (apoB), and homocysteine levels 
from fasting participants (low-density lipoprotein [LDL] 
cholesterol was calculated).
A registered nurse or trained research assistant 
administered a 17-item questionnaire that included 
standard demographic data (age, sex, employment sta-
tus, education level), current and past smoking status, 
number of cigarettes smoked per day, previous diagnosis 
of diabetes and hypertension (“Have you ever been told 
by a doctor that you have diabetes? How long have you 
had diabetes?”), and current medication use. Standard 
techniques were used to obtain anthropometric measures 
(11). Height was measured via metric wall tape and set 
square to the nearest 0.5 cm; weight was measured on a 
balance scale to the nearest 0.1 kg; waist circumference 
was measured at noticeable waist narrowing or at the 
level of the 12th rib, to the nearest 0.5 cm; and hip cir-
cumference was measured at the level of the symphysis 
pubis and the largest area of the buttocks to the nearest 
0.5 cm (11).
Abdominal obesity was defined as waist circumference 
greater than 102 cm for men and greater than 88 cm for 
women (10). Diabetes was defined as a fasting plasma 
glucose of 7.0 mmol/L or higher, or a previous diagnosis; 
impaired fasting glucose was defined as a fasting plasma 
glucose of 6.1 to 6.9 mmol/L (12). Hypertension was 
defined as systolic blood pressure higher than 140 mmHg 
or diastolic blood pressure higher than 90 mmHg, or a 
previous diagnosis. Dyslipidemia was defined as a plasma 
triglyceride level of 1.7 mmol/L or higher and HDL choles-
terol level of 1.03 mmol/L or less for men or 1.30 mmol/L 
or less for women. Metabolic syndrome was defined using 
Adult Treatment Panel III criteria (13). Insulin resistance 
was estimated through the homeostasic model assessment 
(HOMA), which is calculated as follows: [(insulin [pmol] x 
0.139) x (glucose [mmol/L]/22.5)]. Microalbuminuria was 
defined as an albumin-to-creatinine ratio higher than 
2.0 mg/mmol for men and higher than 2.8 mg/mmol for 
women. Neuropathy was defined as presence of numbness, 
tingling, pain, and loss of protective sensation determined 
through application of the 10-g Semmes-Weinstein mono-
filament wire system (Sensory Testing Systems, Baton 
Rouge, Louisiana) (14). A registered nurse completed the 
foot examination and applied the 10-g monofilament. The 
University of Manitoba Health Research Ethics Board 
approved the project. 
Statistical analyses were completed by using SPSS ver-
sion 16 for Windows (IBM, Chicago, Illinois). We used χ2 
tests to detect differences between the sexes for chronic 
disease prevalence, risk factors, and sociodemographic 
variables. We compared differences between the sexes 
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on variables that were continuously distributed by using 
t tests or Mann-Whitney tests for variables with a non-
normal distribution. Differences in the number of chronic 
health conditions by age group and sex and number of 
comorbidities by hypertensive status were determined 
by using χ2 tests. Tests were 2-tailed and differences 
were considered significant at P < .05. We used logistic 
regression to estimate odds ratios (ORs) for obesity and 
microalbuminuria with 95% confidence intervals (CIs). 
Participants with missing values were excluded from 
analyses. No pattern was found for missing values by sex, 
age group, chronic disease, or risk factor variables.
Results
The demographic and health status characteristics of the 
study sample describe a young population with low educa-
tion and high unemployment (Table 1). The prevalence 
of smoking, diabetes, hypertension, and overweight and 
obesity was high among study participants. Waist circum-
ference was available for 259 of the 264 obese participants; 
96% (250 of 259) had waist circumferences that placed 
them at high risk for adverse health outcomes (9). We 
found no significant differences between men and women 
in prevalence of diabetes or hypertension. However, the 
prevalence of dyslipidemia among women (38%) was sig-
nificantly higher than among men (26%).
Overall obesity and abdominal obesity
We used BMI and waist circumference to classify 
participants as obese by age and sex (Figure 1). Almost 
50% of men and 65% of women were obese as defined by 
BMI, and 53% of men and 81% of women had abdominal 
obesity. Obesity was more common among women than 
men according to BMI (χ2 = 14.62, P < .001) and abdomi-
nal obesity (χ2 = 41.38, P < .001). The prevalence of BMI 
≥30 kg/m2 was higher among women aged 18 to 29 years 
than among men of the same age group (χ2 = 9.06, P < 
.01). Abdominal obesity was significantly more common 
for women than for men in all age groups except 40 to 49 
years. Three-quarters of women aged 18 to 29 years had 
abdominal obesity (Figure 1).
Given the differences in obesity between men and 
women and the high prevalence of abdominal obesity, 
we determined factors associated with abdominal obesity 
for each sex by using multivariable backward stepwise 
logistic regression. Variables included in the models were 
those that were significantly associated with abdominal 
obesity in bivariate analyses. For women those variables 
were age; systolic and diastolic blood pressure; triglycer-
ide, apoA1, and apoB levels; insulin resistance; education; 
and employment status. For men variables included in the 
model were age; systolic and diastolic blood pressure; tri-
glyceride, apoA1, and apoB levels; insulin resistance; and 
microalbuminuria (Table 2).
For women, the odds of abdominal obesity increased 
with diastolic blood pressure and insulin resistance. In 
addition, the odds of obesity were lower for women who 
were employed than for those who were unemployed. 
Among men, abdominal obesity was associated with 
increasing age, insulin resistance, lower apoA1, and 
higher apoB levels.
Comorbidities
We determined the extent of comorbidity among this 
population for 4 chronic conditions: obesity, diabetes, 
hypertension, and dyslipidemia. The distribution of chron-
ic conditions by age and sex (Figure 2) showed that women 
aged 18 to 29 and aged 50 or older had significantly more 
chronic conditions than men of the same age groups. 
Twenty-two percent (16 of 73) of men and 43% (30 of 69) 
of women aged 18 to 29 had 2 or more preventable chronic 
conditions. Among participants with abdominal obesity, 
48% (147 of 303) had hypertension and 35% (111 of 313) 
Figure 1. Prevalence of obesity by age and sex in a Canadian First Nation 
population. Abbreviation: BMI, body mass index. Abdominal obesity was 
defined as waist circumference greater than 102 cm for men and greater 
than 88 cm for women.
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had diabetes. Thirty-seven percent (54 of 147) of the 
hypertension and 26% (29 of 111) of diabetes cases among 
these participants were undiagnosed.
Undiagnosed hypertension
Overall, 22% (72 of 337) of study participants had undiag-
nosed hypertension. We compared the extent of comorbidi-
ty for participants with newly diagnosed hypertension and 
2 groups: 1) participants who were not hypertensive and 
2) participants with a previous diagnosis of hypertension 
(Table 3). Participants with newly diagnosed hypertension 
were significantly more likely to have more chronic condi-
tions than were the normotensive participants. However, 
we found no significant differences in extent of comorbid-
ity between those with newly diagnosed hypertension and 
those with previously diagnosed hypertension. In terms of 
outcomes, the adjusted odds of microalbuminuria among 
people with newly diagnosed hypertension were almost 
2 times higher than among those without hypertension. 
The adjusted odds of microalbuminura among those with 
previously diagnosed hypertension were almost 5 times 
higher than among those without hypertension.
Discussion
The prevalence of obesity in the study population is among 
the highest reported for a Canadian First Nation commu-
nity on a reserve (6,7) and is substantially higher than that 
among the general Canadian (4) and off-reserve Aboriginal 
populations (4,15), whether the studies used self-reported 
data (4,6) or direct measurement (15). The high prevalence of 
obesity in the study population is concerning given the eti-
ologic role of obesity in diabetes, heart disease, stroke, and 
some cancers. The prevalence of diabetes that we found is 
one of the highest reported among Canadian First Nation 
populations (6,7,16).
One finding of concern is the high prevalence of obesity 
among young adults, especially young women of reproduc-
tive age. The relationships between maternal obesity and 
gestational diabetes, type 2 diabetes, poor birth outcomes, 
and development of obesity and type 2 diabetes among 
offspring are well documented (17-20). Thus, the preva-
lence of obesity in this young study population warrants 
intervention. These findings are important for 2 reasons: 
1) participants developed chronic conditions at young ages, 
and 2)  hypertension and diabetes cases were undiagnosed 
among a large proportion of obese participants.
Results from logistic regression confirmed established 
associations between obesity and plasma lipid levels, 
hypertension, insulin resistance, and sociodemographic 
factors in the study population. The sex-specific regres-
sion analyses did not include lipids as a predictive factor 
for abdominal obesity among women. We offer 2 possible 
reasons for this. First, the prevalence of abdominal obesity 
was high among women in all age groups but the presence 
of abnormal lipid levels was not. These age differences 
may have been blunted because our outcome (obesity) 
was present in all age groups. Second, previous research 
has shown significant sex differences in the relationship 
between adiposity and plasma lipids (21). Because abnor-
mal lipid levels did occur among women, this finding war-
rants further examination.
We found a high prevalence of comorbidity even among 
the youngest age groups. The Diabetes and Related con-
ditions in Urban Indigenous people in the Darwin region 
(DRUID) study also found high numbers of cardiovascular 
comorbidities among Australian Aborigines, and a higher 
number of comorbidities with increasing age (22). A large 
proportion of the study participants had undiagnosed 
diabetes and hypertension, despite the known strong 
correlations among obesity, diabetes, dyslipidemia, and 
hypertension (23) (we could not determine the extent 
of undiagnosed dyslipidemia among study participants 
because we did not ask them to self-report abnor-
mal lipid levels). In a previous study, risk factors for 
not having blood pressure measured included male 
sex, never being married, not having a regular physi-
Figure 2. Percentage of sample with chronic conditions (obesity, diabetes, 
hypertension, dyslipidemia) by age and sex in a Canadian First Nation popu-
lation.
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cian, being younger, and belonging to an Aboriginal 
or other ethnic minority group (24). In our study, the 
likelihood of not having hypertension diagnosed was 
higher for men (OR, 3.27; 95% CI, 1.74-6.10; P < .01) 
and younger participants (OR, 1.04; 95% CI, 1.01-1.07; 
P < .001).
In our study, the undiagnosed hypertension was not 
benign. The extent of comorbidity among participants with 
newly diagnosed hypertension was similar to that for those 
with previously diagnosed hypertension. In addition, the 
risk for microalbuminuria was significantly higher among 
participants with newly diagnosed hypertension compared 
with those without hypertension but not significantly dif-
ferent between those with newly diagnosed hypertension 
and those with previously diagnosed hypertension. This 
suggests that newly diagnosed hypertension among partic-
ipants had existed for some time. The association between 
hypertension and outcomes such as CVD and stroke war-
rants vigilant screening on the part of health care provid-
ers, especially in high-risk populations. Some participants 
in our “newly diagnosed” group may have been told by a 
physician that they did have hypertension, but they may 
not have remembered or they may have not understood. 
However, none were receiving antihypertensive treat-
ment, so they probably had not received a hypertension 
diagnosis before our study.
The study is subject to limitations. First, our sample was 
based on volunteers and therefore may not be representa-
tive of the community as a whole or of other Canadian 
First Nation communities. A screening study based on a 
volunteer sample may attract primarily healthy people 
who are motivated to learn more about their health, 
resulting in an underestimation of illness. On the other 
hand, a screening study can attract people who already 
have health problems and are seeking additional medical 
assistance, which may result in an overestimation of the 
prevalence of illness in a population. We do not think our 
sample was overrepresented by either group because men 
and women were equally represented, and the age distri-
bution of our sample matched that of the eligible popula-
tion (10). Another indication that the prevalence of illness 
in the community was not overstated is that only half of 
the community members known to have diabetes partici-
pated in the study. None of the 15 people with end-stage 
renal disease participated, and only 3 of 10 community 
members with amputations participated (10). The preva-
lence of chronic disease and risk factors that we report are 
not substantially out of line with previous research.
A second limitation is the use of a fasting glucose test 
rather than a glucose tolerance test. More people with 
diabetes may have been identified if 2-h glucose tolerance 
tests were conducted. However, our protocol is acceptable 
for epidemiologic research. A third limitation is that we 
did not validate the self-reported hypertension or diabetes 
status measures with local health care providers, so we 
may have underestimated self-reported prevalence and 
therefore overestimated undiagnosed cases. However, we 
have previously reported lack of adherence with standards 
of care in this community in relation to foot examinations 
among people with diabetes (10), so participants may not 
have been tested for diabetes and hypertension even when 
indicated. Finally, the study is cross-sectional, so we can-
not infer the temporal sequence of events.
The prevalence of obesity in this population is among 
the highest reported among Canadian First Nation popu-
lations, particularly among women in their reproductive 
years. The extent of obesity-related comorbidity in this 
population is high even among young adults, and women 
at almost every age have a significantly higher rate of 
comorbidity than do men. A sizable proportion of partici-
pants have undiagnosed hypertension that may have been 
present for some time, given the significant associations 
with the other chronic diseases and microalbuminuria. 
The prevalence of cardiovascular and renal disease risk 
factors in this population may portend a larger prevalence 
of cardiovascular and renal disease. In addition, given the 
influence of maternal obesity and diabetes on the health 
of offspring, an increase in childhood obesity and type 2 
diabetes could occur in the community.
An increasing prevalence of obesity and obesity-related 
conditions is not inevitable, however. Many prevention 
activities are under way. First, a research intervention in 
the community is focused on preventing gestational dia-
betes through controlling weight gain during pregnancy 
with exercise and diet. Second, the community operates 
a fitness center that has good equipment and instruction. 
Third, the health center offers education on diet, exercise, 
and wellness. Fourth, walking groups for youth and adults 
are organized through the health center. Fifth, activity 
programs for young people operate out of the local schools. 
However, given the well-established effect of obesity on 
health, continued surveillance of chronic disease and risk 
factors is warranted, as are further health promotion and 
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health education initiatives. We continue to work with the 
community to develop and evaluate primary and second-
ary prevention activities.
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Tables
Table 1. Characteristics of First Nation Population (N = 483), 
Manitoba, Canada, 2003
Characteristica Value
Sex, n (%)
Men 20 (8)
Women 2 (2)
Age, y, mean (SD) .8 (12.)
Education (n = 469), n (%)
Grade 9 or higher 220 ()
Lower than grade 9 29 ()
Employment status (n = 476), n (%)
Employed 1 (29)
Unemployed 9 (1)
Ever smoked (n = 477), n (%)
Yes 91 (82)
No 8 (18)
Current smoker (n = 471), n (%)
Yes 9 ()
No 122 (2)
BMI, kg/m2 (n = 468), n (%)
<2.0  (1)
2.0-29.9 128 (2)
≥30.0 2 ()
Metabolic syndromeb (n = 475), n (%) 22 ()
Abdominal obesityc  (n = 464), n (%) 1 (8)
Diabetesd (n = 483), n (%) 10 (29)
Hypertensione (n = 472), n (%) 201 ()
Dyslipidemiaf (n = 483), n (%) 1 (2)
Microalbuminuriag (n = 466), n (%) 9 (20)
 
Abbreviations: SD, standard deviation; BMI, body mass index. 
a Numerators vary from  to 8 because not all participants completed 
the full protocol. 
b Defined using Adult Treatment Panel III criteria (1). 
c Defined as a waist circumference of >102 cm for men and >88 cm for 
women. 
d Defined as a previous diagnosis or fasting blood glucose ≥7.0 mmol/L. 
e Defined as systolic blood pressure >10 mm Hg or diastolic blood pressure 
>90 mm Hg or previous diagnosis. 
f Defined as plasma triglyceride level ≥1.7 mmol/L and HDL cholesterol level 
≤1.03 mmol/L for men or ≤1.30 mmol/L for women. 
g Defined as an albumin-to-creatinine ratio >2.0 mg/mmol for men and >2.8 
mg/mmol for women.
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Table 2. Odds of Abdominal Obesity by Sex, First Nation Population (N = 483), Manitoba, Canada, 2003
Sex Risk Factor β (SE) OR (95% CI) P Valuea
Women
Currently employed −1.16 (0.45) 0.1 (0.1-0.) .01
Diastolic blood pressure 0.0 (0.02) 1.0 (1.01-1.10) .0
Insulin resistance 1.1 (0.20) 0.1 (0.1-0.) .01
Men
Age 0.0 (0.01) 1.0 (1.02-1.08) .001
ApoA1 −3.06 (1.20) 0.0 (0-0.9) .01
ApoB 1. (0.8) . (1.22-1.) .02
Insulin resistance 0. (0.08) 1.0 (1.19-1.) <.001
 
Abbreviations: SE, standard error; OR, odds ratio; CI, confidence interval; apo, apolipoprotein.  
a Calculated by logistic regression.
Table 3. Comorbidities and Risk for Microalbuminuria by Hypertension Status, First Nation Population, Manitoba, Canada, 
2003 
Participants’ hypertension status 
(N = 453)b
No. of Participants (%) Risk for Microalbuminuriaa
No. of comorbidities
P Valuec β (SE) Odds Ratio P Valuec0 1 2 3
No hypertension (n = 2) 111 (2) 88 () 0 (19) 1 () 1 [Reference] 1 [Reference] 1.00 1 [Reference]
Newly diagnosed hypertension (n 
= 2) 
1 (2) 20 (28) 19 (2) 1 (22) <.001 0. (0.8-0.82) 1.92 <.001
Previously diagnosed hypertension 
(n = 118) 
18 (1)  (1) 8 (2) 2 (22) .1 1. (1.22-1.8) . <.001
 
Abbreviation: SE, standard error. 
a Adjusted for age and sex. Those with newly diagnosed hypertension had no significant difference in risk for microalbuminuria compared with those with previ-
ously diagnosed hypertension. 
b In this analysis, we included only participants for whom values were available for all variables. 
c Calculated by using χ2 test.
